Herpes simplex virus amplicon delivery of a hypoxia-inducible angiogenic inhibitor blocks capillary formation in hepatocellular carcinoma

Keyphrases

• Hepatocellular Carcinoma 100%
• Amplicon 100%
• Herpes Simplex Virus 100%
• Hypoxia-inducible 100%
• Capillary Formation 100%
• Fetal Liver kinase-1 100%
• Angiogenic Inhibitors 100%
• SK-Hep1 54%
• Vascular Endothelial Growth Factor 36%
• Tumor 18%
• Hypoxia 18%
• Normoxia 18%
• Western Blot 18%
• Hepatoblastoma 18%
• Virus 9%
• Angiogenesis 9%
• Tumor Growth 9%
• Endothelial Cells 9%
• Gene Delivery 9%
• Normoxic 9%
• Capillary 9%
• Growth Factor Pathway 9%
• Athymic Mice 9%
• Human Umbilical Vein Endothelial Cells (HUVECs) 9%
• Tumor Angiogenesis 9%
• Tumor Hypoxia 9%
• Cell-based Assay 9%
• Vascular Endothelial Growth Factor Expression 9%
• Hypoxia-responsive 9%
• Vessel Formation 9%
• Human Hepatoma Cells 9%
• Incompetence 9%
• New Vessels 9%
• Genetically Engineered 9%

Immunology and Microbiology

• Amplicon 100%
• Herpes Simplex Virus 100%
• Capillary 100%
• Kinase Insert Domain Receptor 100%
• Vasculotropin 45%
• Western Blot 18%
• Angiogenesis 18%
• Gene Targeting 9%
• Nude Mouse 9%
• Enhancer Region 9%
• Cell Assay 9%
• Umbilical Vein Endothelial Cell 9%
• Flank 9%
• Tumor Hypoxia 9%
• Hepatoma Cell 9%
• Virus 9%
• Replication 9%
• Endothelial Cells 9%

Neuroscience

• Herpes Simplex Virus 100%
• Amplicon 100%
• Kinase Insert Domain Receptor 100%
• Vascular Endothelial Growth Factor 27%
• Western Blot 18%
• Angiogenesis 18%
• VEGF Receptors 18%
• Gene Delivery 9%
• Enhancer Region 9%
• Human Umbilical Vein Endothelial Cell 9%